Neuroscience News
Neuroscience News is an independent open access science magazine that has been reporting on neuroscience research since 2001. They cover topics such as brain research, AI, psychology, mental health and neurotech. The articles are written by various authors and provide the latest and trending news in the field of neuroscience.
93%
The Daily's Verdict
This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.
Bias
98%
Examples:
- The articles provided show a slight bias towards reporting negative or potentially concerning aspects of scientific research.
Conflicts of Interest
98%
Examples:
- There are no clear conflicts of interest reported in the articles.
Contradictions
90%
Examples:
- In some articles, contradictions are found in the information presented. For example, it is mentioned that diets rich in sugar accelerate biological aging but also that a diet linked to lower risk for chronic disease is associated with slower biological aging.
Deceptions
80%
Examples:
- Some articles may be misleading to readers by presenting only one side of a story or by using sensational language in the title.
Recent Articles
Healthy Diets with Less Sugar: Slowing Down Biological Aging
Broke On: Monday, 29 July 2024A recent study links healthy diets, particularly those low in added sugar and rich in vitamins and minerals, to a slower rate of epigenetic aging. The UC San Francisco research found each gram of added sugar consumed increases epigenetic age. While some studies suggest vegan diets may also contribute to younger biological ages, it's crucial to consider the full context before drawing conclusions. New Insights into Alzheimer's Disease: Reelin, Neurofibrillary Tangles, and Emerging Biomarkers
Broke On: Monday, 29 July 2024Alzheimer's disease is a progressive neurodegenerative disorder characterized by memory loss, cognitive decline, and behavioral changes. Recent research reveals its complex nature, focusing on pathological hallmarks - amyloid plaques and tau tangles. New findings suggest that maintaining adequate levels of Reelin protein might protect against amyloid plaque formation. Additionally, understanding cellular responses to neurofibrillary tangles could lead to potential therapeutic strategies. New biomarkers in cerebrospinal fluid offer hope for early detection and prediction. Chimpanzees' Rapid Communication: Turn-Taking Gestures Similar to Human Conversations
Broke On: Monday, 22 July 2024A study published in Current Biology reveals that chimpanzees communicate with each other in rapid back-and-forth gestures, similar to human conversation. With turn-taking averaging around 120 milliseconds, this suggests shared evolutionary mechanisms driving social communication in both species. The study found variation in timing between communities and most interactions consisted of a single gesture, but extended exchanges occurred during food or grooming negotiations. Psilocybin's Lasting Impact on Brain Activity: A Week-Long Disruption of the Default Mode Network
Broke On: Wednesday, 17 July 2024In a groundbreaking study, researchers at Washington University School of Medicine found that psilocybin, a psychedelic compound in magic mushrooms, disrupted brain activity in the default mode network for weeks after consumption. This loss of synchrony may explain altered perceptions and potential therapeutic benefits for conditions like depression and PTSD. New Studies Reveal Contrasting Impacts of AI on Creativity in Writing: Enhancing Individual Creativity, Yet Reducing Collective Diversity and Raising Copyright Concerns
Broke On: Tuesday, 09 July 2024Two studies published in the Science Advances journal explore the impact of Artificial Intelligence on creativity in writing. The first study, led by researchers from the University of Exeter and UCL School of Management, found that AI enhances individual creativity but reduces collective diversity when generating novel story ideas. However, a second study conducted by Anil Doshi and Oliver Hauser from the University of Exeter revealed concerns over copyright infringement in the use of generative AI in creative industries like book publishing. Semaglutide Linked to Increased Risk of NAION: Study Finds Hazard Ratios of 4.28 and 7.64 in Type 2 Diabetes and Overweight Populations, Respectively
Broke On: Wednesday, 03 July 2024A recent study published in JAMA Ophthalmology found that patients taking semaglutide, a medication for diabetes and obesity, had a significantly higher risk of developing Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), which can cause vision loss. The incidence rate was 4.28 times higher in type 2 diabetes patients and 7.64 times higher in overweight or obese patients taking semaglutide compared to non-GLP-1 RA medications. New Study Finds Anxiety May Double the Risk of Developing Parkinson's Disease in People Over 50
Broke On: Tuesday, 25 June 2024New research indicates that individuals over 50 with anxiety have a higher risk of developing Parkinson's disease, according to a study published in the British Journal of General Practice. The findings suggest that those with anxiety are twice as likely to develop the neurodegenerative disorder, even after accounting for age and other factors. Further investigation is required to understand how anxiety relates to early symptoms and progression of Parkinson's disease. New Discoveries Reveal Compassionate Side of Neanderthals: Care for a Child with Down Syndrome 273,000 Years Ago
Broke On: Thursday, 27 June 2024A Neanderthal child with Down syndrome, named Tina, lived to age 6 despite severe hearing loss and imbalance problems in Spain 273,000 years ago. Researchers discovered abnormalities associated with Down syndrome from her inner ear reconstruction. The demanding lifestyle of Neanderthals suggests they provided extensive care based on altruism rather than reciprocation. UK's First Successful Deep Brain Stimulation for Epilepsy: Oran's Life-Changing Story
Broke On: Sunday, 23 June 2024In a groundbreaking trial at Great Ormond Street Hospital, the first UK child with severe epilepsy, identified as Oran, undergoes successful deep brain stimulation (DBS) treatment. The innovative therapy targets the thalamus to block electrical pathways and prevent seizures from spreading. Oran's life-changing experience marks a new era in epilepsy treatment with a rechargeable device that significantly improves upon previous models. New Study Uncovers Link Between Resilience, Brain Function, and Healthy Gut Microbiomes
Broke On: Friday, 21 June 2024A new study published in Nature Mental Health reveals that resilient individuals exhibit improved brain function and healthier gut microbiomes, with reduced inflammation and stronger gut barriers compared to less resilient people. Led by Arpana Gupta from UCLA's Goodman-Luskin Microbiome Center, this research is the first of its kind to explore the connection between resilience, brain function, and gut health.